Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial,Leukemia

当前位置： X-MOL 学术 › Leukemia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial
Leukemia ( IF 12.8 ) Pub Date : , DOI: 10.1038/leu.2017.258
S Ailawadhi , J R Mikhael , B R LaPlant , K M Laumann , S Kumar , V Roy , D Dingli , P L Bergsagel , F K Buadi , S V Rajkumar , R Fonseca , M A Gertz , P Kapoor , T Sher , S R Hayman , A K Stewart , A Dispenzieri , R A Kyle , W I Gonsalves , C B Reeder , Y Lin , R S Go , N Leung , T Kourelis , J A Lust , S J Russell , A A Chanan-Khan , M Q Lacy

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

Leukemia, Published online: 1 September 2017; doi:10.1038/leu.2017.258

中文翻译：